Raymond W. Cohen - 30 Sep 2026 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Reporting relationship: Director
Issuer ticker: KMTS
Reported as of: 30 Sep 2026
Net transaction value: -$97,504
SEC form: 4
Accepted by SEC: 01 Oct 2026, 18:00:09 UTC
Prior SEC filing: 10 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Traci S. Umberger as attorney-in-fact for Raymond W. Cohen

Key filing fact

Raymond W. Cohen filed Form 4 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 01 Oct 2026.

Key facts

This page summarizes Raymond W. Cohen's Form 4 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Oct 2026, 18:00.

Change

Previous filing in this sequence was filed on 10 Sep 2026.
Current net transaction value: -$97,504.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258288 Primary reporting owner

COHEN RAYMOND W

Relationship: Director
Address: C/O KESTRA MEDICAL TECHNOLOGIES LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND
Signature: /s/ Traci S. Umberger as attorney-in-fact for Raymond W. Cohen
Signature date: 01 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS transaction

Common Shares

Sale

Transaction value: $97,504
Shares: -3,330
Change %: -5.7%
Price: $29.28
Shares after: 54,790
Date: 30 Sep 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

Footnote F2

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $29.2800 to $29.2900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.